The study investigated the relationship between arterial stiffness calculated using the cardio–ankle vascular index (CAVI), diagnosis of type 2 diabetes mellitus and type 2 diabetes-related cardiovascular complications, in patients with type 2 diabetes mellitus (type 2 diabetes) and nondiabetic patients.
Methods
A retrospective cross-sectional study was conducted in patients with type 2 diabetes and age-matched nondiabetic patients. CAVI was measured using an automatic vascular screening system. Parameters associated with type 2 diabetes and cardiovascular complications were also measured.
Results
A total of 51 patients with type 2 diabetes and 59 nondiabetic patients were enrolled in the study. Significantly higher CAVI scores were observed in patients with type 2 diabetes compared with nondiabetic patients (mean ± SD: 9.55 ± 1.13 versus 8.54 ± 0.94, respectively). Multivariate linear regression analyses demonstrated that age was the only significant factor influencing the CAVI score, in patients with type 2 diabetes.
Conclusion
Patients with type 2 diabetes had an increased risk of arterial stiffness, based on the CAVI score, compared with nondiabetic patients; this, in turn, could increase their risk of developing other cardiovascular complications.
KhangYHChoSIKimHR. Risks for cardiovascular disease, stroke, ischaemic heart disease, and diabetes mellitus associated with the metabolic syndrome using the new harmonised definition: findings from nationally representative longitudinal data from an Asian population. Atherosclerosis2010; 213: 579–585.
2.
Grupo de Trabajo Diabetes MellitusY. Enfermedad Cardiovascular de la Sociedad Española de Diabetes. Diabetes mellitus and cardiovascular risk. Recommendations of the Working Group of Diabetes Mellitus and Cardiovascular Disease of the Spanish Diabetes Society 2009. Endocrinol Nutr2010; 57: 220–226. [in Spanish].
3.
HenryRR. Preventing cardiovascular complications of type 2 diabetes: focus on lipid management. Clin Diabetes2001; 19: 113–120.
4.
NickenigGRölingJStrehlowK. Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms. Circulation1998; 98: 2453–2460.
5.
JesminSSakumaIHattoriY. Role of angiotensin II in altered expression of molecules responsible for coronary matrix remodeling in insulin-resistant diabetic rats. Arterioscler Thromb Vasc Biol2003; 23: 2021–2026.
6.
RizzoniDPorteriEGuelfiD. Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus. Circulation2001; 103: 1238–1244.
7.
BrownleeMCeramiAVlassaraH. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. New Engl J Med1988; 318: 1315–1321.
8.
LaurentSBoutouyriePAsmarR. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension2001; 37: 1236–1241.
9.
CruickshankKRisteLAndersonSG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?Circulation2002; 106: 2085–2090.
10.
StrainWDChaturvediNDockeryF. Increased arterial stiffness in Europeans and African Caribbeans with type 2 diabetes cannot be accounted for by conventional cardiovascular risk factors. Am J Hypertens2006; 19: 889–896.
11.
TakenoKMitaTNakayamaS. Masked hypertension, endothelial dysfunction, and arterial stiffness in type 2 diabetes mellitus: a pilot study. Am J Hypertens2012; 25: 165–170.
12.
NamekataTSuzukiKIshizukaN. Establishing baseline criteria of cardio-ankle vascular index as a new indicator of arteriosclerosis: a cross-sectional study. BMC Cardiovasc Disord2011; 11: 51–51.
13.
KawasakiTSasayamaSYagiS. Non-invasive assessment of the age related changes in stiffness of major branches of the human arteries. Cardiovasc Res1987; 21: 678–687.
14.
KimKJLeeBWKimHM. Associations between cardio-ankle vascular index and microvascular complications in type 2 diabetes mellitus patients. J Atheroscler Thromb2011; 18: 328–336.
15.
TakakiAOgawaHWakeyamaT. Cardio-ankle vascular index is superior to brachial-ankle pulse wave velocity as an index of arterial stiffness. Hypertens Res2008; 31: 1347–1355.
16.
MiyoshiTDoiMHirohataS. Cardio-ankle vascular index is independently associated with the severity of coronary atherosclerosis and left ventricular function in patients with ischemic heart disease. J Atheroscler Thromb2010; 17: 249–258.
17.
LeeJAKimDHYuSJ. Association of serum albumin and homocysteine levels and cardio-ankle vascular index in patients with continuous ambulatory peritoneal dialysis. Korean J Intern Med2006; 21: 33–38.
18.
MineokaYFukuiMTanakaM. Relationship between cardio-ankle vascular index (CAVI) and coronary artery calcification (CAC) in patients with type 2 diabetes mellitus. Heart Vessels2012; 27: 160–165.
19.
NagayamaDSaikiAEndoK. Improvement of cardio-ankle vascular index by glimepiride in type 2 diabetic patients. Int J Clin Pract2010; 64: 1796–1801.
20.
GenuthSAlbertiKGBennettP. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care2003; 26: 3160–3167.
21.
ChalmersJ. The 1999 WHO–ISH Guidelines for the Management of Hypertension. Med J Aust1999; 171: 458–459.
22.
Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Circulation1979; 59: 607–609.
23.
FriedewaldWTLevyRIFredricksonDS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem1972; 18: 499–502.
24.
MatthewsDRHoskerJPRudenskiAS. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia1985; 28: 412–419.
25.
KubozonoTMiyataMUeyamaK. Clinical significance and reproducibility of new arterial distensibility index. Circ J2007; 71: 89–94.
26.
ShiraiKUtinoJOtsukaK. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J Atheroscler Thromb2006; 13: 101–107.
27.
WakabayashiIMasudaH. Association of acute-phase reactants with arterial stiffness in patients with type 2 diabetes mellitus. Clin Chim Acta2006; 365: 230–235.
28.
CardosoCRFerreiraMTLeiteNC. Microvascular degenerative complications are associated with increased aortic stiffness in type 2 diabetic patients. Atherosclerosis2009; 205: 472–476.
29.
LyonsDRoySPatelM. Impaired nitric oxide-mediated vasodilatation and total body nitric oxide production in healthy old age. Clin Sci (Lond)1997; 93: 519–525.
30.
MatzRLSchottCStocletJC. Age-related endothelial dysfunction with respect to nitric oxide, endothelium-derived hyperpolarizing factor and cyclooxygenase products. Physiol Res2000; 49: 11–18.
31.
NakamuraKTomaruTYamamuraS. Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis. Circ J2008; 72: 598–604.
32.
OkuraTWatanabeSKurataM. Relationship between cardio-ankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension. Hypertens Res2007; 30: 335–340.
33.
YambeMTomiyamaHHirayamaY. Arterial stiffening as a possible risk factor for both atherosclerosis and diastolic heart failure. Hypertens Res2004; 27: 625–631.
34.
IbataJSasakiHKakimotoT. Cardio-ankle vascular index measures arterial wall stiffness independent of blood pressure. Diabetes Res Clin Pract2008; 80: 265–270.
35.
YambeTYoshizawaMSaijoY. Brachio-ankle pulse wave velocity and cardio-ankle vascular index (CAVI). Biomed Pharmacother2004; 58(suppl 1): S95–S98.
36.
KimESMoonSDKimHS. Diabetic peripheral neuropathy is associated with increased arterial stiffness without changes in carotid intima–media thickness in type 2 diabetes. Diabetes Care2011; 34: 1403–1405.
37.
IzuharaMShiojiKKadotaS. Relationship of cardio-ankle vascular index (CAVI) to carotid and coronary arteriosclerosis. Circ J2008; 72: 1762–1767.
38.
SolanoMPGoldbergRB. Lipid management in type 2 diabetes. Clin Diabetes2006; 24: 27–32.
39.
VokonasPSKannelWBCupplesLA. Epidemiology and risk of hypertension in the elderly: the Framingham Study. J Hypertens Suppl1988; 6: S3–S9.
40.
TakataYOsawaHKurataM. Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes. Hypertension2008; 51: 534–539.
